https://www.europereloaded.com/india-develops-ivermectin-home-treatment-covid-kit-for-less-than-3-per-person/India Develops Ivermectin Home Treatment CV Kit for Lessthan $3 Per Person
January19, 2021 TLBStaff HEALTH, WORLD 2
ER Editor: For those with a very strong stomach, we recommend this absurd and shocking story of an elderly New York State woman, whose family had to fight in the courts to get ivermectin RE-PRESCRIBEDfor her after she had already been admitted to a hospital ICU as a legitimate, seriously ill Covid patient and had taken ivermectin on a first round. (Only after the family pushed for this drug to be used in the first place, however). This treatment turned her advanced condition aroundrapidly. But once she was transferred from ICU to elsewhere within the hospital, doctors there resolutely REFUSED to re-prescribe it for her, hence the court action. And even then, doctors still refused. Note that while the judge gave permission for the use of ivermectin, it had to be her FAMILY DOCTOR who could reinstate it as a treatment, and the judge stated this requirement only verbally. See the article by Brian Shilhavy from Vaccine Impact of January 15, 2021: New York Supreme Court Judge Saves 80-Year-Old Patient fromDeath by Ordering Hospital to Give Life-Saving Ivermectin.
Meanwhile, elderly people are dying in Norway and elsewhere from experimental gene-therapy ‘vaccines’ (they’re not) that haven’t been fully trialled on healthy people. As Shilhavy observes,
The genocide against the elderly is in full swing rightnow in the U.S. and around the world.
As we have recently reported, assisted living centers whoare now injecting their residents with the experimental Pfizer mRNA COVIDinjections are killing off many of them, particularly the oldest residentsabove the age of 80.
As we reported yesterday, the Norwegian Medicines Agencyannounced that 23 people died after receiving the experimental Pfizer mRNACOVID injections, and that is out of only 25,000 injections nationwide. All ofthem were over the age of 80. (ER: This number has reached 33.) See:
23 Seniors Have Died in Norway After Receiving the PfizerExperimental COVID mRNA Injection
Earlier this week we reported that a nursing home inAuburn, New York, had zero deaths attributed to COVID until theystarted injecting the residents with one of the experimental mRNACOVID injections, and then 24 died. See:
24 Dead and 137 Infected at NY Nursing Home After ExperimentalCOVID Injections
The biggest tragedy in these deaths, which reveals crimesagainst humanity and the medical system’s low regard for the lives ofour elderly, is that these experimental injections are not even needed, asthere are effective and safe treatments for COVID already available,where doctors are reporting a near 100% success rate in treating theirpatients with early treatment.
India has been distributing science-based home caretreatments since at least November for a cost of little more than 2 bucks. Our featured image comes from the site below, where you can buy this treatment. While we are not endorsing any form of medical treatment or recommending readers purchase it for themselves, just a click on this link to India Mart shows how easy it is to get something so simple and cheap as the Indian Government’s Ziverdo Kit, while people in western countries are being heavily propagandized and pressured to takeuntested gene therapies with serious side effects and death: https://www.indiamart.com/proddetail/ziverdo-kit-10999972812.html.
They must really hate us.
********
India develops COVID treatment kit for less than $3 perperson with ‘miraculous’ ivermectin
‘Utilizing early treatment with hydroxychloroquine andivermectin, the densely populated India, which has four times the population ofthe U.S., has less than half of the coronavirus related deaths’
PATRICK DELANEY for LIFESITE NEWS
Dr. Pierre Kory, founding member of FrontLine Covid-19 Critical Care Alliance (FLCCC) has testified before the U.S.Senate Homeland Security Committee on the effectiveness of ivermectin
.
INDIA, January 18, 2021 (LifeSiteNews)— While the United States continues its aggressive military roll-out of novel, expensive and dangerous pharmaceutical vaccines, Indiahas developed a “miraculously” effective and safe COVID-19 treatment kit whichcosts merely $2.65 per person and has helped put the nation’s case and fatalityrates in “steep decline.”
Last month, several medical experts testified beforethe U.S. Senate Homeland Security Committee in favor of authorizing ivermectinfor early treatment of the novel coronavirus. Among them, Dr. PierreKory, founding member of Front Line Covid-19Critical Care Alliance (FLCCC), explained that ivermectin, a NobelPrize–winning anti-parasitic agent, “basically obliterates transmissionof this virus,” with “miraculous effectiveness.”
Ivermectin has been the subject of dozens of studies andanecdotal success stories since it was found to reduce COVID-19 in a laboratory lastJune.
“I’ve been treating COVID pretty much every single daysince the onset,” Kory said. “When I say ‘miracle,’ I do not use that termlightly…that is a scientific recommendation based on mountains of data that hasemerged in the last three months.”
FLCCC has developed a treatmentregimen incorporating ivermectin, which the group claims has ledto up to 83% lower-than-average COVID-19 death rates in hospitals that haveapplied it.
However, the Food and Drug Administration (FDA) has refused emergency authorization of ivermectin to treatcoronavirus, stating for months that “[m]ore testing is needed.”
In contrast, on the other side of the world, India hasembraced the treatment protocol specified by Dr. Kory and his colleagues and isnow manufacturing this product under the brand name “Ziverdo Kit” and it onlycosts approximately $2.65 per person.
Though the U.S. National Institutes of Health (NIH) recommends notreatment for those suffering from SARS-COV-2 “unless the patient ishospitalized and requires oxygen,” in India, they began treatingcoronavirus patients early, including the use of hydroxychloroquine (HCQ).
Dr. Makarand Paranjpe and his wife, both 77 year-old Indianphysicians, fully recovered from the COVID-19 virus using early treatment lastNovember, TrialSiteNews (TSN) reports. She usedhydroxychloroquine, and he took ivermectin.
“Without any treatment, we know that the virus enters thecells and replicates there,” Paranjpe said. “They can create disease that getsmuch more severe.” Stopping such replication as early as possible is the simplefunction of these inexpensive and safe treatments.
Last March, as debates raged in the U.S. over the merits ofHCQ, following President Trump’s endorsement of the drug, India hadalready recommended it in its national guidelines, affirmingit “should be used as early in the disease course as possible…and should beavoided in patients with severe disease.”
Following the June discovery of ivermectin’sefficacy in treating the virus, along with significant subsequent testing,the largest state in their nation, Uttar Pradesh (UP) (pop. 230 million), announced inAugust that it was replacing their HCQ protocol with ivermectin forthe prevention and treatment of COVID-19.
“By the end of 2020, Uttar Pradesh — which distributed freeivermectin for home care — had the second-lowest fatality rate inIndia at 0.26 per 100,000 residents in December. Only the state of Bihar,with 128 million residents, was lower, and it, too, recommends ivermectin,” writes Mary Beth Pfeiffer ofTSN.
By further comparison, utilizing early treatment with HCQand ivermectin, the densely populated India, which has four times thepopulation of the U.S., has less than half of the coronavirus related deaths.“And India isn’t just beating the poorly performing U.S. In all, 98nations have higher death rates than India,” Pfeiffer writes.
Dr. Anil K. Chaurasia, a physician in UP, affirmed thatstarting in mid-September, “a clear decline in COVID cases and fatalities inIndia was noticeable … [and the] “steep decline in cases and fatalities isstill continuing.”
The same results hold for neighboring Bangladesh, one ofthe most densely populated nations in the world, where doctors also utilize anivermectin home care therapy, and they have an even lower fatality rate, ranking 128thinthe world.
Kory cited similar results in Peru, Argentina, Brazil andseveral other South American countries demonstrating the effectiveness ofivermectin.
For example, in his written testimony to the senatecommittee, he related that in Peru, “the peak in deathsoccurred at the time of distribution” of ivermectin, which the country approvedfor COVID-19 treatment in late spring. Every Peruvian state witnessed“rapid and sustained reduction in both case counts and death rates in patients”as ivermectin circulated, he wrote.
In the face of such new and broad evidence, however, theFDA and NIH have nonetheless remained unwavering in their rejection ofivermectin as a tool to combat coronavirus, and instead have maintained acentral focus on vaccines.
And while HCQ and ivermectin have been around for manydecades, and are known to be quite safe, serious concerns remain regarding theseCOVID-19 vaccines which have been rushed through the process of development,testing, approval, and now distribution, with a new “messenger RNA” technology, no industry-standard animal trials, nor anysufficient studies on long-term effects.
These concerns include “allergic” and “potentially fatalreactions,” as well as concerns about the potential impact on fertility.
The FDA even drew up a document this fall listing the possibleside-effects from a COVID-19 vaccine, including strokes, encephalitis,auto-immune disease, birth defects, Kawasaki disease, and death.
Present reports reveal that hundreds of individuals injected with thesevaccines have been admitted to the hospital, and at leasttwo have died.
Though these U.S. regulatory agencies maintain “[m]oretesting is needed,” before approving ivermectin, Pfeiffer observes, “[m]oreinformation is always better. But at what point, in a pandemic, is thereenough?”
Kory forcefully asserted to the senate, “the amount ofevidence that I have presented far exceed the level required for acompassionate use authorization as defined by the FDA.”
Ivermectin “needs to be immediately adopted systematicallynationally and globally, period,” he insisted.
“You can use this medication in just about any condition,”he said. “It is safe, inexpensive, [and] widely available.”
